期刊文献+

骨肽注射液对去卵巢大鼠骨组织中TGF-β1及Fas的影响 被引量:4

The Effect of Ossotide injection on TGF-β1 and Fas in Bone in Ovariectomized Rats.
下载PDF
导出
摘要 目的:观察骨肽注射液对去卵巢大鼠骨组织中转化生长因子-β(TGF-β1)及F as的影响。方法:复制骨质疏松症大鼠模型,假手术组仅摘除小段肠系膜。各组动物术后,以骨肽为治疗药物,苯甲酸雌二醇注射液为阳性对照,生理盐水为阴性对照,分别给药3个月后处死取材。应用免疫组化sABC法检测骨组织中TGF-β1和F as抗原的表达情况。骨肽高、低剂量组骨组织中TGF-β1及F as抗原表达的阳性颗粒的平均灰度、阳性单位值较模型组明显增高(P<0.05);而与假手术组比较则无明显差异(P>0.05)。结论:骨肽注射液能促进成骨细胞形成活性、抑制破骨细胞吸收活性,其作用机理之一可能是通过调控某些影响骨形成及骨吸收的局部细胞生长因子及凋亡基因而达到的。 Objective:To investigate the effects of Ossotide injection on TGF-β1 and Fas in bone in ovariectomized Rats. Methods:Ovariectomy was used in all of model, Ossotide and Estrogen. The small segment mesentery was cut in Sham. All animal were fed in nomal ways for three months after operation. Rats of Ossotide were given Ossotide injection, rats of Estrogen were given nilestriol as positive control, and rats of Model were given Saline as negative control for three months respectively. The methods of immunohistochemistry sABC were used to detect the expressions of Transforming growth factor-β1(TGF-β1 ) and Fas antigen in bone. Results:TGF-β1 was expressed chiefly in osteoblastic membrane and plasm but Fas antigen was expressed chiefly in osteoclastic plasm in bone. Average gray scale and positive unit of Ossotide by expressions of TGF-β1 in osteoblast and Fas in osteoclast singnificantly increased more than that of model(P〈 0. 05) and these data of Ossotide have no difference compared with Sham (P〈0. 05). Conclusions:Ossotide injection can promate the activity of bone formation of osteoblast and depress the activity of bone absorption of osteoclast. One of mechanism of Ossotide injection on Osteoporosis is induced by' ovariectomy in rats is the regulation of some local cell growth factor and apoptosis gene affecting bone formation and bone absorption.
出处 《中国中医骨伤科杂志》 CAS 2005年第6期42-45,共4页 Chinese Journal of Traditional Medical Traumatology & Orthopedics
关键词 骨肽注射液 转化生长因子-Β FAS抗原 去卵巢大鼠 Ossotide injection Transforming growth factor-β1(TGF-β1 ) Fas antigen Ovariectomized rats
  • 相关文献

参考文献9

  • 1Greenfield EM, Bi Y, Miyauchi A. Regulation of osteoclast activity. Life Sci, 1999;65:1087~1102.
  • 2Sagraves R. Evaluating therapeutic modalities for prevention and treatment of postmenopausal osteoporosis. Ann Pharmacother,2003,37 : 744-746.
  • 3Suda T, Nakamura I, Jimi E, et al. Regulation of osteoclast function. J Bone Miner Res, 1997,12 : 869-879.
  • 4Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGF/TRANCE/RANKL,regulates osteoclast differentation and function. Biocbem Biopbs Res Common, 1999,256:449-455.
  • 5Christodoulou C,Cooper C. What is osteoporosis? Postgrad Med J 2003,79:133-138.
  • 6Choi EM, Suh KS, Kim YS, et al. Soybeab ethanol extract increases the function of osteoblastic MC3T3- E1 cell. Phyto chemismtry 2001 ; 56 (7):733- 739.
  • 7Randy N, Rosier MD, Ragis J,et al. The potential role of Transforming growth factor bata in fracture healing. Clin Orthop & Res, 1998,355:294.
  • 8梁晓萍,肖学吕,徐宜英,吴伏娜,钟紫茹.生长因子与老年性骨质疏松症相关性的临床研究[J].中国骨质疏松杂志,2001,7(2):128-130. 被引量:14
  • 9王晓敏,于世凤,庞淑珍,刘忠厚.阿仑膦酸盐诱导破骨细胞凋亡FAS基因的表达[J].中国骨质疏松杂志,1998,4(4):30-33. 被引量:5

二级参考文献5

共引文献17

同被引文献78

引证文献4

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部